Chemical compound
Pharmaceutical compound
Trimazosin is a sympatholytic alpha-1 blocker.[1][2]
References
- ^ van Kalken CK, van der Meulen J, Oe PL, Vriesendorp R, Donker AJ (1986). “Pharmacokinetics of trimazosin and its effects on blood pressure, renal function and proteinuria during short-term therapy of patients with impaired renal function and hypertension”. Eur. J. Clin. Pharmacol. 31 (1): 63–8. doi:10.1007/BF00870988. PMID 3780829. S2CID 19123951.
- ^ U.S. patent 3,669,968
| Sympatholytics (antagonize α-adrenergic vasoconstriction) | |||||
|---|---|---|---|---|---|
| Other antagonists |
| ||||
| |||||
| α1 |
| ||||
|---|---|---|---|---|---|
| α2 |
| ||||
| β |
| ||||
| Phenylpiperazines |
|
|---|---|
| Benzylpiperazines | |
| Naphthylpiperazines | |
| Quinolinylpiperazines | |
| Diphenylalkylpiperazines |
|
| Pyrimidinylpiperazines | |
| Pyridinylpiperazines | |
| Benzo(iso)thiazolylpiperazines | |
| Tricyclic-linked piperazines |
|
| Others/uncategorized | |